Glenmark Life Sciences Limited

    Glenmark Life Sciences Limited

    NNSE:GLS
    - -
    INR
    - -
    - -
    27.28P/E
    Glenmark Life Sciences Limited
    NSE:GLS
    (National Stock Exchange of India)

    Recent

    price

    - -

    P/E

    ratio

    27.28

    div

    yld

    - -

    ROIC.AI

    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    INR
    111.06
    121.96
    151.92
    177.62
    167.13
    178.31
    177.58
    Revenue per Share
    23.89
    25.55
    28.69
    35.63
    38.11
    38.43
    36.05
    Basic EPS, GAAP
    0.08
    11.74
    26.13
    39.6
    11.69
    23.22
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    10.95
    31.5
    22.5
    - -
    Dividend per Share
    0.16
    0.16
    61.44
    88.99
    91.94
    107.43
    - -
    Book Value per Share
    6.67
    32.2
    60.79
    173.91
    173.04
    189.14
    - -
    Tangible Book Value per Share
    123
    123
    123
    118
    123
    123
    123
    Basic Weighted Avg Shares
    13,608
    14,943
    18,614
    20,874
    20,478
    21,848
    21,755
    Sales/Revenue/Turnover
    30.08
    29.7
    30.18
    27.73
    29.34
    28.48
    26.1
    Operating Margin (%)
    193
    294
    334
    379
    421
    535
    592
    Depreciation Expense
    2,927
    3,131
    3,516
    4,187
    4,670
    4,709
    4,417
    Net Income, GAAP
    27.53
    25.64
    25.35
    25.88
    25.72
    25.41
    25.45
    Effective Tax Rate (%)
    21.51
    20.95
    18.89
    20.06
    22.8
    21.55
    20.3
    Profit Margin (%)
    -4,497
    -1,473
    1,776
    13,806
    13,538
    14,772
    - -
    Working Capital
    - -
    - -
    - -
    12
    171
    148
    - -
    LT Debt
    881
    4,017
    7,527
    20,543
    21,382
    23,323
    - -
    Total Equity
    - -
    131.86
    71.29
    30.26
    21.05
    20.53
    - -
    Return on Invested Capital (%)
    - -
    17,063.06
    110.49
    48.79
    42.59
    38.08
    1,055.38
    Return on Capital (%)
    - -
    15,974.39
    93.17
    46.56
    42.99
    38.55
    - -
    Return on Common Equity (%)

    Capital Structure

    INR

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    - -
    26
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    134
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    - -
    123
    - -
    Market Capitalization
    106,490
    129,568
    120,482

    Working Capital

    INR

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    - -
    20,961
    - -
    Cash, Cash Equivalents & STI
    - -
    5,302
    - -
    Accounts Receivable, Net
    - -
    7,751
    - -
    Inventories
    - -
    6,892
    - -
    Total Current Liabilities
    - -
    4,637
    - -
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    26
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    INR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    125.86%
    9.08%
    Free Cash Flow
    - -
    2,820.67%
    98.69%
    Net Income, GAAP
    - -
    10.15%
    0.84%
    Sales/Revenue/Turnover
    - -
    10.26%
    6.69%
    Total Cash Common Dividend
    - -
    - -
    -28.56%

    Quarterly Revenue

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    4,899
    5,093
    5,407
    5,079
    20,478
    2024
    5,785
    5,954
    5,728
    4,382
    21,848
    2025
    5,886
    5,069
    6,418
    - -
    - -

    Quarterly Earnings Per Share

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    8.87
    8.72
    8.57
    - -
    38.11
    2024
    11.05
    9.69
    9.69
    - -
    38.43
    2025
    9.1
    7.78
    11.18
    - -
    - -

    Quarterly Dividends Per Share

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    31.5
    2024
    - -
    - -
    - -
    - -
    22.5
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business